Malignant Otitis Externa: A Novel Stratification Protocol for Predicting Treatment Outcomes.

Area of Science:

• Otolaryngology
• Infectious Diseases
• Radiology

Background:

• Malignant otitis externa (MOE) is a severe infection of the external auditory canal.
• Current treatment guidelines lack stratification for disease severity.
• Predicting outcomes and tailoring treatment for MOE remains challenging.

Purpose of the Study:

• To stratify patients with malignant otitis externa into severe and nonsevere categories.
• To predict treatment courses and patient outcomes based on this stratification.
• To identify potential indicators for more aggressive management in severe MOE cases.

Main Methods:

• Retrospective review of 28 patients diagnosed with MOE between 2004 and 2014 at a tertiary center.
• Patients were stratified into severe and nonsevere groups based on clinical (cranial nerve VII palsy, relapse, surgery) and radiographic findings, and culture results.
• Outcomes assessed included cure, disease-specific mortality, antibiotic duration, and hospital admissions.

Main Results:

• 43% of patients were classified into the severe MOE group.
• The severe MOE group experienced significantly more adverse disease-specific outcomes (7/12 vs. 0/16, p=0.002), including a 42% disease-specific mortality rate.
• Severe MOE cases had longer antibiotic courses (12.8 vs. 6.9 weeks) and more relapses compared to nonsevere cases.

Conclusions:

• A distinct subgroup of malignant otitis externa patients may be less responsive to standard antibiotic and debridement therapies.
• Clinical and radiographic criteria can effectively stratify MOE into severe and nonsevere categories.
• Severe MOE patients have a higher risk of mortality and poorer treatment response, potentially necessitating surgical intervention.